Authors: KYNDT X PASTURELMICHON U HACHULLA E HATRON PY REMYJARDIN M

Citation: X. Kyndt et al., INTRAVENOUS (IV) CYCLOPHOSPHAMIDE FOR TREATMENT OF SYSTEMIC-SCLEROSISWITH INTERSTITIAL LUNG-DISEASE, Arthritis and rheumatism, 41(9), 1998, pp. 415-415

Authors: KYNDT X HEBBAR M QUEYREL V HACHULLA E HATRON PY DEVULDER B

Citation: X. Kyndt et al., SYSTEMIC-SCLEROSIS AND MALIGNANCY - ASSES SMENT OF RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CANCER IN 123 PATIENTS WITH SYSTEMIC-SCLEROSIS, La Revue de medecine interne, 18(7), 1997, pp. 528-532

Authors: LESAVRE P KYNDT X VANHILLE P REUMAUX D GUILLEVIN L NOEL LH

Citation: P. Lesavre et al., SERIAL ANCA TESTING HAS LIMITED VALUE DURING THE FOLLOW-UP OF DISEASE-ACTIVITY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS, Sarcoidosis vasculitis and diffuse lung diseases, 13(3), 1996, pp. 246-248

Authors: KYNDT X REUMAUX D BRIDOUX F LEMAITRE V HATRON PY TRIBOUT B VANHILLE P

Citation: X. Kyndt et al., PAUCI-IMMUNE GLOMERULONEPHRITIS - RELAPSES AND ASCA MONITORING, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2649-2649